News

Visit Kalms Consulting at MEDICA 2018

It is our pleasure to announce that we will be attending MEDICA.

MEDICA is the world’s largest medical event. This year, it will be from the 12th – 15th of November, at Messe Düsseldorf; and attracts experts from all around the world: in the fields of business, research and politics. You will be able to attend multiple panels and discussions on the newest trends in the medical industry, see the newest technological innovations and meet with professionals from around the world.

We would like to invite you to the Welcome Reception for the joint Berlin-Brandenburg booth. It will be at hall 15 booth F42 on Monday, November 12th, 2018, from 6:00pm-10:00pm. While we are at MEDICA, feel free to visit us at the Berlin-Brandenburg booth (hall 15 at booth F42).

We welcome your questions and topics that you would like to discuss with us. The whole Kalms Group (Kalms Consulting GmbH & Kalms Operations) will be present; giving you the opportunity to ask us about anything, from reimbursement and market access to logistics and warehousing.

We have also opened our appointment bookings service. Here you can setup an appointment to speak with renowned experts about commercialization in Europe, market access & reimbursement in the USA, market access in China and European medical device law. We are happy to have these experts at our booth and hope you will enjoy their knowledge and their distinguished experience as well.

We look forward to seeing you at MEDICA 2018!

Info box
We Look Forward to Seeing You

MEDICA 2018 - 12th - 15th of November, at Messe Düsseldorf
Feel free to visit us at the Berlin-Brandenburg booth (Hall 15 F42).

Meet our Experts

Book an appointment with one of our experts below.
Our senior consultants will be available throughout the fair at the booth.

Monday, November 12th

Commercialization in Europe

The European market is a very important world leading and price setting market. For a successful launch in Europe, it is necessary to have an extensive knowledge about the relevant systems and country specifics. Marco Kalms will be there to answer all your questions about market access, intelligence and market development. He and his team can provide your business unique navigation through the different European healthcare systems on your way to commercialization.

Marco Kalms

Marco Kalms has more than 25 years of experience in operational, strategic and market access leadership positions in the healthcare industry. As a long-time Sales Manager, Country Manager Germany and Managing Director Europe, he contributed significantly to the growth of American Medical Systems, Inc. In his role as Managing Director Europe, Mr. Kalms developed market access strategies to open up new markets in the EMEA regions. It is this mixture of operational business and market access experience that is an essential part of the expertise the Kalms Consulting team offers to support healthcare companies. For more than 6 years, many international clients have benefited from the services of Kalms Consulting.
Book an Appointment
 

 

Tuesday, November 13th

Market Access and Reimbursement in the USA

The U.S. healthcare system is huge and complex, but nonetheless ripe for companies with novel technologies that can lead innovation and drive improved clinical outcomes. Reimbursement Strategies specializes in working with international companies to navigate the vagaries of the U.S. system for companies seeking to commercialize these technologies. We emphasize the fundamental tenets of success in medtech reimbursement, with a special competence in working with government and commercial insurers to advocate for coverage of new medical devices.

Ed Black

Edward Black specializes in reimbursement strategy, payer relations and health economics for medtech and biotech companies in the US and abroad. Mr. Black is active in several US and international medical technology initiatives and is a frequent international lecturer. Before founding Reimbursement Strategies, LLC in 2008, Mr. Black worked for over 25 years in medical management and hospital and physician relations within the Blue Cross Blue Shield system. In 1995, he was awarded the Outstanding Contribution to the Healthcare Industry citation by Medical Alley Association of Minnesota.
Book an Appointment
 

 

Wednesday, November 14th

Market Access China – How to Successfully Build Business in China

China can be a challenging market, but at the same time is one of the largest markets for medical devices worldwide and offers great rewards when a company succeeds. At MEDICA, we can offer insights into potential market access and business development strategies for the Chinese market and provide a first check if your devices might be a “fit” for the Chinese marketplace.

Dennis Wilkens

Dennis Wilkens is the Kalms Consulting Team’s expert in the Chinese market. His experience includes guiding the market access of western medical device companies into the Chinese Healthcare market; as well as assisting innovative, research-orientated, Chinese companies to enter the German Healthcare market. His wide range of experience in China includes Regulatory Affairs Guidance, Strategy Development, Local Business Development & Marketing, M&A and Licencing.
Book an Appointment
 

 

Thursday, November 15th

Medical Devices – Legal Implications, Liability and MDR

The legal framework for marketing and selling medical devices in the EU is still relatively new and continuously developing. Publicly discussed cases around defective artificial hip joints and manipulated breast implants have led to new case law on the liability of manufacturers and notified bodies, and eventually to the enactment of the EU Regulation on Medical Devices (MDR), to become fully applicable in May 2020. In parallel, health technology assessment of high-risk medical devices has become a prerequisite for the reimbursement of certain types of hospital treatment. We will be at your disposal to discuss the impact of the most recent developments with you.

Dr. Manja Epping

Dr. Manja Epping is co-head of Taylor Wessing’s Life Sciences & Healthcare Industry Group. She advises companies from the pharmaceutical, biotech, medical devices and food sectors on a broad range of regulatory and intellectual property matters. In addition, she advises such companies on manufacturing and distribution agreements, clinical trial agreements, research and development as well as licence agreements.
Book an Appointment

 

Legal Aspects of Reimbursement

The introduction of new medical products in the German healthcare market regularly goes along with initial difficulties in the assumption of costs by the statutory health insurance funds. In principle, the statutory health insurance funds only acknowledge costs for so-called recognised examination and treatment methods. New medical devices or new examination and treatment methods can therefore only be used at the expense of statutory health insurers and other public cost payers if the patient has previously submitted a successful individual case application. We will be happy to explain the basic procedure and how we can support you in securing the assumption of costs.

Dr. Vanessa Christin Vollmar

Dr. Vanessa Christin Vollmar works as a lawyer at the international law firm Taylor Wessing. She specialises in medical law; with a special focus on regulatory issues. Her clients include healthcare providers of all kinds, in particular medical device manufacturers, hospitals and nursing homes. Dr. Vanessa Christin Vollmar advises her clients on questions of licensing, service provision and reimbursement.
Book an Appointment
 

 

 

For individual or additional opportunities for matchmaking with the experts please do not hesitate to contact us via info@kalmsconsulting.com

Published on: October 23, 2018

Whether you need a new plan or a second opinion,
Kalms has the insight you're looking for

Let's talk